$84.3 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$55.19 - $75.59The lowest and highst price in the last 52 weeks.
280.09xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$2.74 (4.07%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Market Cap||$84.3 Billion|
|Enterprise Value||$109 Billion|
|Dividend Yield||$2.74 (4.07%)|
|1 Year Return||-0.8%|
|Outstanding Shares||1.25 Billion|
|Avg 30 Day Volume||7.23 Million|
|Earnings per Share||$0.24|
|Price to Sales Ratio||3.33|
|Price to Book Ratio||4.44|
|Revenue to Enterprise Value||4.26|
|EBIT to Enterprise Value||10.39|
|Total Debt to Enterprise Value||0.28|
|Debt to Equity||1.59|
|Gross Profit||$20.6 Billion|
|Net Income||$301 Million|
|Quarterly Earnings Growth (YoY)||+11.5%|
|Return on Equity||1.59%|
|Return on Assets||0.45%|
|Return on Invested Capital||18.13%|
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: SVB Leerink Global Healthcare ...Business Wire, 4 months ago
Gilead Sciences says Veklury sales made up 25% of the total Q4 revenue. Gilead forecasts up to £18.34 billion of total product sales in fiscal 2021.Invezz, 4 months ago
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced a new partnership with the Wake Forest University School of Divinity, one of the leading academic and fait...Business Wire, 4 months ago